TVARDI THERAPEUTICS, INC. Available-for-sale Securities, Gross Unrealized Loss
TVARDI THERAPEUTICS, INC. (TVRD) reported Available-for-sale Securities, Gross Unrealized Loss of $5.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2016-08-04
- TVARDI THERAPEUTICS, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2016-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2016-03-31 was $5.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 6 month | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $5.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $5.00K 10-Q · filed 2016-05-05 | ||
| 2015-12-31 | $40.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |